JPMorgan analyst Lisa Gill lowered the firm’s price target on Cigna to $370 from $378 and keeps an Overweight rating on the shares. The firm believes the managed care group remains fundamentally well positioned coming out of Q4 but adjusted multiples and ratings across the sector to reflect valuations more in-line with historical levels. In addition, the near-term Medicare Advantage rate outlook is disappointing with the Centers for Medicare and Medicaid Services announcing a 2% preliminary rate cut next year versus the market’s expectation for an increase in the range of 0%-2%, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CI:
- Cigna price target lowered to $348 from $359 at Deutsche Bank
- Cigna price target lowered to $309 from $335 at SVB Securities
- Cigna price target lowered to $320 from $350 at Loop Capital
- Cigna sees FY23 adjusted EPS $24.60, consensus $24.84
- Cigna Reports Strong Fourth Quarter and Full Year 2022 Results, Establishes 2023 Guidance and Increases Dividend